These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Spatiotemporal genomic architecture informs precision oncology in glioblastoma. Lee JK; Wang J; Sa JK; Ladewig E; Lee HO; Lee IH; Kang HJ; Rosenbloom DS; Camara PG; Liu Z; van Nieuwenhuizen P; Jung SW; Choi SW; Kim J; Chen A; Kim KT; Shin S; Seo YJ; Oh JM; Shin YJ; Park CK; Kong DS; Seol HJ; Blumberg A; Lee JI; Iavarone A; Park WY; Rabadan R; Nam DH Nat Genet; 2017 Apr; 49(4):594-599. PubMed ID: 28263318 [TBL] [Abstract][Full Text] [Related]
6. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression. Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962 [TBL] [Abstract][Full Text] [Related]
7. An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testing. Malhotra R; Javle V; Tanwar N; Gowda P; Varghese L; K A; Madhusudhan N; Jaiswal N; K S B; Chatterjee M; Prabhash K; Sreekanthreddy P; Rishi KD; Goswami HM; Veldore VH Front Oncol; 2023; 13():1002792. PubMed ID: 36994199 [TBL] [Abstract][Full Text] [Related]
8. Whole Genome Sequencing-Based Discovery of Structural Variants in Glioblastoma. Wrzeszczynski KO; Felice V; Shah M; Rahman S; Emde AK; Jobanputra V; O Frank M; Darnell RB Methods Mol Biol; 2018; 1741():1-29. PubMed ID: 29392687 [TBL] [Abstract][Full Text] [Related]
9. Patient-derived glioblastoma cell lines with conserved genome profiles of the original tissue. Kim SC; Cho YE; Shin YK; Yu HJ; Chowdhury T; Kim S; Yi KS; Choi CH; Cha SH; Park CK; Ku JL Sci Data; 2023 Jul; 10(1):448. PubMed ID: 37438387 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel genes by whole-exome sequencing can improve gastric cancer precision oncology. Lianos GD; Glantzounis GK; Bali CD; Katsios C; Roukos DH Future Oncol; 2017 Apr; 13(10):883-892. PubMed ID: 27897040 [TBL] [Abstract][Full Text] [Related]
11. Correlation of genetic alterations by whole-exome sequencing with clinical outcomes of glioblastoma patients from the Lebanese population. Saadeh FS; Morsi RZ; El-Kurdi A; Nemer G; Mahfouz R; Charafeddine M; Khoury J; Najjar MW; Khoueiry P; Assi HI PLoS One; 2020; 15(11):e0242793. PubMed ID: 33237934 [TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing revealed mutational profiles of giant cell glioblastomas. Shi ZF; Li KK; Kwan JSH; Yang RR; Aibaidula A; Tang Q; Bao Y; Mao Y; Chen H; Ng HK Brain Pathol; 2019 Nov; 29(6):782-792. PubMed ID: 30861589 [TBL] [Abstract][Full Text] [Related]
13. Translational validation of personalized treatment strategy based on genetic characteristics of glioblastoma. Oh YT; Cho HJ; Kim J; Lee JH; Rho K; Seo YJ; Choi YS; Jung HJ; Song HS; Kong DS; Seol HJ; Lee JI; Yoon Y; Kim S; Nam DH; Joo KM PLoS One; 2014; 9(8):e103327. PubMed ID: 25084005 [TBL] [Abstract][Full Text] [Related]